fashion -WSS

fashion

author：comprehensive 2025-09-28 08:53:45 - browse：1

President Joe Biden speaks and gestures at a podium outdoor — In addition to medical devices, the United States will raise tariffs on $18 billion worth of products including electric vehicles, batteries, and semiconductors. MANDEL NGAN/AFP via Getty Images

WASHINGTON — The Biden administration announced Tuesday that it’s raising taxes on a range of imported products from China, including syringes, needles, and surgical gloves.

Pitched as a plan to support American workers, the tariffs are meant to protect domestic manufacturers from China’s “unfair trade practices” and “artificially low-priced exports.” In addition to medical devices, the United States will raise tariffs on $18 billion worth of products including electric vehicles, batteries, and semiconductors.

Related: Drug supplies for millions would be jeopardized by U.S. crackdown on China biopharma industry, trade group says

The inclusion of syringes comes after the Food and Drug Administration’s repeated warnings to U.S. medical providers about quality issues with plastic syringes from China. The agency first alerted consumers in November 2023 about leaks and breaks associated with Chinese syringes. In March, the FDA called attention to three warning letters it sent to firms in China for selling syringes that had not received FDA clearance. It has since sent a warning letter to Cardinal Health.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Scientists boost immune system in aging mice by making it youthful

knowledge

WSS

Patient advocates debate FDA's accelerated approval process

Scientists boost immune system in aging mice by making it youthful

The Readout: Lenmeldy, GLP

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Eliminate the waiting period for sterilization covered by Medicaid

Study says nonprofit hospitals fall short in charity care spending

explore

fashion

Related: Drug supplies for millions would be jeopardized by U.S. crackdown on China biopharma industry, trade group says

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

entertainment

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Readout Newsletter: Merck, Vertex, and Viking updates

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

FDA's naming rule on biosimilars has undermined competition

DIEP, the 'gold standard' of breast reconstruction, is under threat

Steward Health Care has deal to sell doctor network to UnitedHealth

Heart attack and stroke risk calculators need revising

Covid vaccine financial winners and losers, from Pfizer to Novavax

As demand for Covid shots wanes, Moderna seeks its next success

Eliminate the waiting period for sterilization covered by Medicaid

Wikipedia

Patient advocates debate FDA's accelerated approval process

Eliminate the waiting period for sterilization covered by Medicaid

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

Oprah kicked off a national conversation on obesity. Let's have it

Study says nonprofit hospitals fall short in charity care spending

Abortion pill Supreme Court ruling could impact entire drug industry

knowledge

explore

knowledge

knowledge